Literature DB >> 25940998

Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease.

Amy M Hellman1, Shital P Shah2, Stephanie M Pawlowski3, John E Duda4, James F Morley4.   

Abstract

BACKGROUND: Lightheadedness on standing is a disabling symptom in Parkinson's disease associated with orthostatic hypotension and is thought to represent cardiovascular autonomic dysfunction. Traditional orthostatic blood pressures are normal in some patients with lightheadedness and other measures of cardiovascular dysautonomia can be insensitive. In this study, we used continuous non-invasive arterial pressure monitoring to measure beat-to-beat changes in blood pressure and heart rate on standing and during Valsalva as a potential marker of autonomic dysfunction.
METHODS: Subjects had a diagnosis of Parkinson's disease with or without documented orthostatic hypotension. Each participant underwent traditional measurement of orthostatic blood pressure and heart rate as well as measurement of beat-to-beat blood pressure and heart rate using continuous non-invasive arterial pressure monitoring during Valsalva maneuver and in response to standing. Orthostatic change in blood pressure and heart rate, and frequencies of normal and abnormal blood pressure responses to Valsalva maneuver were analyzed.
RESULTS: In subjects without documented orthostatic hypotension, there was a higher proportion of abnormal blood pressure responses to Valsalva in subjects with symptoms of lightheadedness or dizziness upon standing compared to those without symptoms (p = 0.03). Additionally, the proportion of abnormal blood pressure responses during Valsalva observed in symptomatic subjects without orthostatic hypotension was indistinguishable from those with documented orthostatic hypotension (p = 0.7).
CONCLUSIONS: Our findings suggest that continuous non-invasive arterial pressure monitoring may be more sensitive than traditional measurement of orthostatic blood pressure to detect subtle cardiac dysautonomia in Parkinson's disease and helpful in the diagnosis of unexplained lightheadedness. Published by Elsevier Ltd.

Entities:  

Keywords:  Autonomic dysfunction; Orthostatic hypotension; Parkinson's disease

Mesh:

Year:  2015        PMID: 25940998     DOI: 10.1016/j.parkreldis.2015.04.016

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

1.  An upper body garment with integrated sensors for people with neurological disorders - early development and evaluation.

Authors:  Margit Alt Murphy; Filip Bergquist; Bengt Hagström; Niina Hernández; Dongni Johansson; Fredrik Ohlsson; Leif Sandsjö; Jan Wipenmyr; Kristina Malmgren
Journal:  BMC Biomed Eng       Date:  2019-01-30

Review 2.  Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development.

Authors:  Spyros Papapetropoulos; Angela Pontius; Elizabeth Finger; Virginija Karrenbauer; David S Lynch; Matthew Brennan; Samantha Zappia; Wolfgang Koehler; Ludger Schoels; Stefanie N Hayer; Takuya Konno; Takeshi Ikeuchi; Troy Lund; Jennifer Orthmann-Murphy; Florian Eichler; Zbigniew K Wszolek
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

Review 3.  Technology in Parkinson's disease: Challenges and opportunities.

Authors:  Alberto J Espay; Paolo Bonato; Fatta B Nahab; Walter Maetzler; John M Dean; Jochen Klucken; Bjoern M Eskofier; Aristide Merola; Fay Horak; Anthony E Lang; Ralf Reilmann; Joe Giuffrida; Alice Nieuwboer; Malcolm Horne; Max A Little; Irene Litvan; Tanya Simuni; E Ray Dorsey; Michelle A Burack; Ken Kubota; Anita Kamondi; Catarina Godinho; Jean-Francois Daneault; Georgia Mitsi; Lothar Krinke; Jeffery M Hausdorff; Bastiaan R Bloem; Spyros Papapetropoulos
Journal:  Mov Disord       Date:  2016-04-29       Impact factor: 10.338

Review 4.  Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research.

Authors:  B Y Valdovinos; J S Modica; R B Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.